160 related articles for article (PubMed ID: 7065481)
1. Oral theophylline disposition in cystic fibrosis.
Georgitis JW; Eigen H; Warner R; Gonzales MA
Ann Allergy; 1982 Mar; 48(3):175-7. PubMed ID: 7065481
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of theophylline and bioavailability of a sustained release theophylline preparation in patients with cystic fibrosis.
Valet SB; Schwartz RH; Brooks JG
Ann Allergy; 1983 Mar; 50(3):161-5. PubMed ID: 6829982
[TBL] [Abstract][Full Text] [Related]
3. [Pharmacokinetics of oral theophylline. Comparison between asthmatic and cystic fibrosis patients].
Repetto T; Marianelli L; Valenza T; Rosselli P; Messori A
Pediatr Med Chir; 1985; 7(6):823-5. PubMed ID: 3837249
[TBL] [Abstract][Full Text] [Related]
4. Montelukast pharmacokinetics in cystic fibrosis.
Graff GR; Weber A; Wessler-Starman D; Smith AL
J Pediatr; 2003 Jan; 142(1):53-6. PubMed ID: 12520255
[TBL] [Abstract][Full Text] [Related]
5. The paradoxical effect of adrenergic and methylxanthine drugs in cystic fibrosis.
Shapiro GG; Bamman J; Kanarek P; Bierman CW
Pediatrics; 1976 Nov; 58(5):740-3. PubMed ID: 790287
[TBL] [Abstract][Full Text] [Related]
6. Theophylline disposition in cystic fibrosis.
Isles A; Spino M; Tabachnik E; Levison H; Thiessen J; MacLeod S
Am Rev Respir Dis; 1983 Apr; 127(4):417-21. PubMed ID: 6838048
[TBL] [Abstract][Full Text] [Related]
7. Probenecid pharmacokinetics in cystic fibrosis.
Weber A; de Groot R; Ramsey B; Williams-Warren J; Smith A
Dev Pharmacol Ther; 1991; 16(1):7-12. PubMed ID: 1879255
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of amiloride after inhalation and oral administration in adolescents and adults with cystic fibrosis.
Jones KM; Liao E; Hohneker K; Turpin S; Henry MM; Selinger K; Hsyu PH; Boucher RC; Knowles MR; Dukes GE
Pharmacotherapy; 1997; 17(2):263-70. PubMed ID: 9085317
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetic evaluation of cefsulodin in children with and without cystic fibrosis treated for infectious diseases.
Michalsen H; Bergan T; Solberg R
Methods Find Exp Clin Pharmacol; 1986 Nov; 8(11):685-7. PubMed ID: 3807469
[TBL] [Abstract][Full Text] [Related]
10. [Adaptation of the oral dosage of theophylline to the asthmatic child. Value of a kinetic test by the intravenous route].
Albertini M; Lapalus P; Maurin S; Boutte P; Mariani R
Arch Fr Pediatr; 1982 Nov; 39(9):671-5. PubMed ID: 7165461
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of azlocillin in children with and without cystic fibrosis treated for infectious diseases.
Michalsen H; Bergan T
Methods Find Exp Clin Pharmacol; 1986 Dec; 8(12):727-9. PubMed ID: 3807473
[TBL] [Abstract][Full Text] [Related]
12. [Theophylline in childhood asthma. Pharmacokinetic and clinical study (author's transl)].
Bellon G; Plasse JC; Satta S; Barbier Y; Gilly R
Rev Fr Mal Respir; 1981; 9(2):113-21. PubMed ID: 7255850
[TBL] [Abstract][Full Text] [Related]
13. [Serum theophylline levels after oral administration in a group of asthmatic children].
Escorihuela R; Llerena P; Royo F; Lillo Lillo M; de la Morena E; Borges Domingo T; López-Linares M
An Esp Pediatr; 1982 Dec; 17(6):461-5. PubMed ID: 7183217
[TBL] [Abstract][Full Text] [Related]
14. Pancreatitis among patients with cystic fibrosis: correlation with pancreatic status and genotype.
De Boeck K; Weren M; Proesmans M; Kerem E
Pediatrics; 2005 Apr; 115(4):e463-9. PubMed ID: 15772171
[TBL] [Abstract][Full Text] [Related]
15. Theophylline disposition in patients with hepatic cirrhosis.
Piafsky KM; Sitar DS; Rangno RE; Ogilvie RI
N Engl J Med; 1977 Jun; 296(26):1495-7. PubMed ID: 865528
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the Chiou method for determining theophylline dosages.
Johnson MH; Burkle WS
Clin Pharm; 1984; 3(2):174-8. PubMed ID: 6723223
[TBL] [Abstract][Full Text] [Related]
17. Use of pharmacokinetic profile in evaluating patients with repeatedly low theophylline concentrations.
Georgitis JW; Szefler SJ; Baswell B; Shen DD
Ann Allergy; 1984 Sep; 53(3):231-5. PubMed ID: 6476482
[TBL] [Abstract][Full Text] [Related]
18. Conversion from intravenous aminophylline to sustained-release theophylline: computer simulation versus in vivo results.
Hatton RC; Gotz VP; Robinson JD; Russell WL; Ryerson GG
Clin Pharm; 1983; 2(4):347-52. PubMed ID: 6883961
[TBL] [Abstract][Full Text] [Related]
19. Enhanced renal excretion of dicloxacillin in patients with cystic fibrosis.
Jusko WJ; Mosovich LL; Gerbracht LM; Mattar ME; Yaffe SJ
Pediatrics; 1975 Dec; 56(6):1038-44. PubMed ID: 1196754
[TBL] [Abstract][Full Text] [Related]
20. The theophylline disposition after caffeine administration in liver cirrhosis: an index of liver function.
Hartleb M; Romańczyk T; Becker A; Mańczyk I; Waluga M; Spalińska M; Zieliński M
Ital J Gastroenterol; 1992; 24(6):332-7. PubMed ID: 1515659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
